Related Experiment Video
Updated: Aug 4, 2026
11:07
Inducing Acute Lung Injury in Mice by Direct Intratracheal Lipopolysaccharide Instillation
Published on: July 6, 2019
Drug-induced inflammatory responses to the lung
1Safety Assessment, AstraZeneca, Södertälje, Sweden. anita.enininger@astrazeneca.com
Toxicology Letters
|March 18, 2000
Summary
Drug-induced lung toxicity can manifest acutely or insidiously, often involving inflammation. This review explores mechanisms like reactive oxygen species generation in drug-induced lung injury.
Area of Science:
- Pulmonology
- Toxicology
- Pharmacology
Background:
- Drugs can cause lung toxicity, ranging from acute respiratory distress syndrome-like reactions to insidious damage during treatment.
- Inflammation is a key factor in the pathology of drug-induced lung toxicity.
- The precise mechanisms and initial events of drug-induced lung injury remain poorly understood.
Purpose of the Study:
- To discuss mechanistic aspects of drug-induced lung injury.
- To highlight the role of inflammation in drug-induced lung toxicity.
- To explore specific pathways involved in lung damage from medications.
Main Methods:
- Literature review focusing on mechanistic aspects of drug-induced lung injury.
- Discussion of key pathological pathways.
- Synthesis of current knowledge on drug-induced lung damage.
Main Results:
- Drug-induced lung toxicity involves complex mechanisms.
- Reactive oxygen species (ROS) generation is implicated in lung injury.
- Mediator release and alterations in lung phospholipid metabolism contribute to toxicity.
Conclusions:
- Understanding the mechanisms of drug-induced lung injury is crucial for prevention and treatment.
- Further research into pathways like ROS generation is needed.
- Inflammation plays a significant role in the pathogenesis of drug-induced lung damage.
Related Concept Videos
01:27Allergic Drug Reactions
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing numerous...
01:17Drugs Used in Lower Respiratory Disorders: Overview
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:30Drug Toxicity: Allergic Reactions
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...